SpringWorks Therapeutics (SWTX) Investor Presentation - Slideshow

54 ▪ ~25% of ER+ mBC patients progress on endocrine therapy | --- | --- | --- | --- | --- | |----------------------------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------| | ...